Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease in Adults 80-Years-of-Age and Older

The 2016 U.S. Preventive Services Task Force (USPSTF) recommendations regarding aspirin use for primary prevention of cardiovascular disease (CVD) does not provide a specific recommendation for patients 80-years-of-age and older, as efficacy and safety data is lacking.1,2 CVD risk increases with age suggesting that the geriatric population would benefit from aspirin use.3,4 However, this population carries the highest risk of aspirin-related adverse effects so the balance of risk versus benefit is uncertain.
Source: Progress in Cardiovascular Diseases - Category: Cardiology Authors: Tags: Letter to the Editor Source Type: research